Your browser doesn't support javascript.
loading
Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
Niyonzima, Nathalie; Bakke, Siril S; Gregersen, Ida; Holm, Sverre; Sandanger, Øystein; Orrem, Hilde L; Sporsheim, Bjørnar; Ryan, Liv; Kong, Xiang Yi; Dahl, Tuva Børresdatter; Skjelland, Mona; Sørensen, Kirsten Krohg; Rokstad, Anne Mari; Yndestad, Arne; Latz, Eicke; Gullestad, Lars; Andersen, Geir Ø; Damås, Jan Kristian; Aukrust, Pål; Mollnes, Tom E; Halvorsen, Bente; Espevik, Terje.
Afiliação
  • Niyonzima N; Centre of Molecular Inflammation Research, and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Olav Kyrres gate 17, Trondheim 7030, Norway.
  • Bakke SS; Centre of Molecular Inflammation Research, and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Olav Kyrres gate 17, Trondheim 7030, Norway.
  • Gregersen I; Research Institute of Internal Medicine, Oslo University Hospital, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway.
  • Holm S; Research Institute of Internal Medicine, Oslo University Hospital, Norway.
  • Sandanger Ø; Research Institute of Internal Medicine, Oslo University Hospital, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway.
  • Orrem HL; Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
  • Sporsheim B; Centre of Molecular Inflammation Research, and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Olav Kyrres gate 17, Trondheim 7030, Norway.
  • Ryan L; Centre of Molecular Inflammation Research, and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Olav Kyrres gate 17, Trondheim 7030, Norway.
  • Kong XY; Research Institute of Internal Medicine, Oslo University Hospital, Norway.
  • Dahl TB; Research Institute of Internal Medicine, Oslo University Hospital, Norway.
  • Skjelland M; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Neurology, Oslo University Hospital, Norway.
  • Sørensen KK; Research Institute of Internal Medicine, Oslo University Hospital, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway.
  • Rokstad AM; Centre of Molecular Inflammation Research, and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Olav Kyrres gate 17, Trondheim 7030, Norway.
  • Yndestad A; Research Institute of Internal Medicine, Oslo University Hospital, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway.
  • Latz E; Centre of Molecular Inflammation Research, and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Olav Kyrres gate 17, Trondheim 7030, Norway; Institute of Innate Immunity, Biomedical Center, University of Bonn, Germany.
  • Gullestad L; Department of Cardiology, Oslo University Hospital, Norway; KG Jebsen Center for Cardiac Research, and Center for Heart Failure Research, Oslo University Hospital, Norway.
  • Andersen GØ; Department of Cardiology, Oslo University Hospital, Norway.
  • Damås JK; Centre of Molecular Inflammation Research, and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Olav Kyrres gate 17, Trondheim 7030, Norway.
  • Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Norway.
  • Mollnes TE; Centre of Molecular Inflammation Research, and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Olav Kyrres gate 17, Trondheim 7030, Norway; Department of Immunology, Oslo University Hospital, Norway; KG Jebsen TREC, Department of Clinical Medicine, Univ
  • Halvorsen B; Research Institute of Internal Medicine, Oslo University Hospital, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway.
  • Espevik T; Centre of Molecular Inflammation Research, and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Olav Kyrres gate 17, Trondheim 7030, Norway; The Central Norway Regional Health Authority, St. Olavs Hospital HF, Norway. Electronic address: terje.espevik@nt
EBioMedicine ; 60: 102985, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32927275
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Proteínas do Sistema Complemento / Doenças das Artérias Carótidas / Transdução de Sinais / Colesterol / Proteína 3 que Contém Domínio de Pirina da Família NLR Limite: Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Proteínas do Sistema Complemento / Doenças das Artérias Carótidas / Transdução de Sinais / Colesterol / Proteína 3 que Contém Domínio de Pirina da Família NLR Limite: Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Noruega